SEVERE WX : Wind Advisory - High Wind Warning - Winter Weather Advisory View Alerts
STREAMING NOW: Watch Now

Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment

Merck is seeking FDA emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. If authorized, the drug would be the first oral antiviral treatment to fight Covid-19. CNN's Elizabeth Cohen reports.

Posted: Oct 11, 2021 9:24 AM


Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir.

If authorization is granted, the drug, made by Merck and Ridgeback Biotherapeutics, would be the first oral antiviral treatment to fight Covid-19. It comes in capsule form.

Merck said it is asking for authorization for the capsules to treat infected adults who are at risk of progressing to severe Covid-19 disease or hospitalization. Its submission is based on a study that was stopped at the interim point because the drug was working so well in more than 700 patients randomly assigned to take either molnupiravir or a placebo.

"At the interim analysis, molnupiravir reduced the risk of hospitalization or death by approximately 50%; 7.3% of patients who received molnupiravir were either hospitalized or died through Day 29 following randomization, compared with 14.1% of placebo-treated patients," the company said in a statement.

"Through Day 29, no deaths were reported in patients who received molnupiravir, as compared to eight deaths in patients who received placebo." None of the volunteers in the trial had been vaccinated.

"The extraordinary impact of this pandemic demands that we move with unprecedented urgency, and that is what our teams have done by submitting this application for molnupiravir to the FDA within 10 days of receiving the data," Merck CEO and President Robert Davis said in the statement.

Data from the trial has not yet been peer-reviewed or published.

"Merck has been producing molnupiravir at risk and expects to produce 10 million courses of treatment by the end of 2021, with more courses expected to be produced in 2022," the company said.

It has already sold 1.7 million treatment courses to the US government. The company said it will offer tiered pricing to provide access around the world, and will work with generic drug manufacturers to speed availability to low- and middle-income countries.

At a White House Covid-19 briefing last week, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, called the trial results "very encouraging," but said the drug needs close scrutiny by the FDA.

"It is very important that this now must go through the usual process of careful examination of the data by the Food and Drug Administration both for effectiveness, but also for safety, because whenever you introduce a new compound, safety is very important," Fauci said, noting that vaccines remain "our best tools against Covid-19" by preventing infection and illness, rather than treating it.

The-CNN-Wire
™ & © 2021 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 352026

Reported Deaths: 4185
CountyCasesDeaths
Multnomah55306692
Washington38321316
Marion36352445
Clackamas29350304
Lane27309299
Jackson22783304
Deschutes19886124
Umatilla14286144
Linn12617120
Douglas11918241
Josephine9292195
Yamhill8584111
Klamath7765111
Polk719680
Malheur552774
Benton537630
Coos492593
Columbia375743
Jefferson366351
Union316247
Lincoln313338
Wasco282640
Crook277646
Clatsop240729
Baker199228
Tillamook194929
Hood River190137
Morrow183023
Curry178723
Harney110225
Grant98012
Lake89711
Wallowa67312
Gilliam1494
Sherman1463
Wheeler1031
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 4825708

Reported Deaths: 70829
CountyCasesDeaths
Los Angeles147768626443
Riverside3704095008
San Diego3649124169
San Bernardino3574215597
Orange3234075528
Sacramento1584372283
Fresno1451192063
Santa Clara1450041895
Kern1449141615
Alameda1202831381
San Joaquin1022501721
Ventura1008011165
Contra Costa99612995
Stanislaus856421319
Tulare79513958
San Francisco54220644
San Mateo53970622
Monterey50772583
Solano45898340
Santa Barbara45005522
Merced42047579
Sonoma40822402
Placer39118420
Imperial35794764
Kings32587315
San Luis Obispo29797331
Madera23680281
Butte23649265
Shasta23544341
Santa Cruz20928218
Yolo20240248
Marin17644243
El Dorado17083149
Sutter13847172
Napa12855100
Yuba1000882
Tehama9406107
Humboldt9171108
Nevada909490
Mendocino757686
Lassen749946
San Benito741372
Tuolumne680893
Lake6565104
Amador540364
Siskiyou445842
Glenn433632
Calaveras385180
Del Norte357141
Colusa302818
Inyo203540
Mono16565
Plumas16046
Mariposa130815
Trinity86711
Modoc6758
Unassigned1820
Sierra1810
Alpine1030
Out of CA00
Medford
Partly Cloudy
60° wxIcon
Hi: 60° Lo: 35°
Feels Like: 60°
Brookings
Mostly Cloudy
52° wxIcon
Hi: 62° Lo: 40°
Feels Like: 52°
Crater Lake
Mostly Cloudy
60° wxIcon
Hi: 40° Lo: 24°
Feels Like: 60°
Grants Pass
Partly Cloudy
60° wxIcon
Hi: 65° Lo: 34°
Feels Like: 60°
Klamath Falls
Mostly Cloudy
47° wxIcon
Hi: 50° Lo: 30°
Feels Like: 41°
Strong winds tonight
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events